TY - JOUR
T1 - Safety and Efficacy of Cryoablation in Patients With Ventricular Arrhythmias Originating From the Para-Hisian Region
AU - Miyamoto, Koji
AU - Kapa, Suraj
AU - Mulpuru, Siva K.
AU - Deshmukh, Abhishek J.
AU - Asirvatham, Samuel J.
AU - Munger, Thomas M.
AU - Friedman, Paul A.
AU - Packer, Douglas L.
N1 - Funding Information:
Dr. Packer has served as a consultant for Abbott, Aperture Diagnostics, Biosense Webster, Boston Scientific, CardioFocus, Johnson & Johnson Healthcare Systems, Johnson & Johnson, MediaSphere Medical, Medtronic, St. Jude Medical, Siemens, and Spectrum dynamics; has received research funding from Abbott, Biosense Webster, Boston Scientific/EPT, CardioInsight, CardioFocus, Endosense, Hansen Medical, Medtronic, the National Institutes of Health, Robertson Foundation, St. Jude Medical, Siemens, and Thermedical; and has received royalties from Wiley & Sons, Oxford, and St. Jude Medical. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Publisher Copyright:
© 2018 American College of Cardiology Foundation
PY - 2018/3
Y1 - 2018/3
N2 - Objectives: This study aimed to assess the outcome of cryoablation in patients with ventricular arrhythmias (VAs) originating from the para-Hisian region. Background: There are few data regarding the outcome of cryoablation in patients with VAs originating from the para-Hisian region, where there is the risk of injury to the conduction system. Methods: The study analyzed all patients undergoing cryoablation at the Mayo Clinic (Rochester, Minnesota) as part of an ablation for VAs originating from the para-Hisian region. Results: The study population consisted of 10 patients (64 ± 15 years of age, 7 men). Cryoenergy was applied after an unsuccessful radiofrequency (RF) ablation in 8 (80%) patients. The VAs were successfully ablated with cryoablation in 7 (70%) patients; RF ablation after an unsuccessful cryoablation eliminated the VAs at almost the same location with careful monitoring in 1 patient. The authors could not ablate the actual focus because a transient atrioventricular block developed during cryo- and RF energy applications, which led to an unsuccessful ablation in the remaining 2 patients. A complete atrioventricular block occurred during the cryoenergy application in 1 patient, who needed a permanent pacemaker implantation. There were no VA recurrences in 4 of 8 (50%) patients with procedural success during a median follow-up period of 122 days (interquartile range: 43 to 574 days). Conclusions: Cryoablation is clinically effective in some patients with VAs originating from the para-Hisian region, where there is the risk of injury to the conduction system, and therefore should be considered as an alternative to or in addition to RF ablation in these cases. Cryoablation requires care because it can also lead to major complications.
AB - Objectives: This study aimed to assess the outcome of cryoablation in patients with ventricular arrhythmias (VAs) originating from the para-Hisian region. Background: There are few data regarding the outcome of cryoablation in patients with VAs originating from the para-Hisian region, where there is the risk of injury to the conduction system. Methods: The study analyzed all patients undergoing cryoablation at the Mayo Clinic (Rochester, Minnesota) as part of an ablation for VAs originating from the para-Hisian region. Results: The study population consisted of 10 patients (64 ± 15 years of age, 7 men). Cryoenergy was applied after an unsuccessful radiofrequency (RF) ablation in 8 (80%) patients. The VAs were successfully ablated with cryoablation in 7 (70%) patients; RF ablation after an unsuccessful cryoablation eliminated the VAs at almost the same location with careful monitoring in 1 patient. The authors could not ablate the actual focus because a transient atrioventricular block developed during cryo- and RF energy applications, which led to an unsuccessful ablation in the remaining 2 patients. A complete atrioventricular block occurred during the cryoenergy application in 1 patient, who needed a permanent pacemaker implantation. There were no VA recurrences in 4 of 8 (50%) patients with procedural success during a median follow-up period of 122 days (interquartile range: 43 to 574 days). Conclusions: Cryoablation is clinically effective in some patients with VAs originating from the para-Hisian region, where there is the risk of injury to the conduction system, and therefore should be considered as an alternative to or in addition to RF ablation in these cases. Cryoablation requires care because it can also lead to major complications.
KW - cryoablation
KW - para-Hisian region
KW - radiofrequency ablation
KW - ventricular arrhythmias
UR - http://www.scopus.com/inward/record.url?scp=85042646150&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042646150&partnerID=8YFLogxK
U2 - 10.1016/j.jacep.2017.12.013
DO - 10.1016/j.jacep.2017.12.013
M3 - Article
C2 - 30089563
AN - SCOPUS:85042646150
SN - 2405-5018
VL - 4
SP - 366
EP - 373
JO - JACC: Clinical Electrophysiology
JF - JACC: Clinical Electrophysiology
IS - 3
ER -